Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Significant Impact Factors and Establishment of a Clinically Relevant Model

NCT02011022 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT02011022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02011022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Analysis of High Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Significant Impact Factors and Establishment of a Clinically Relevant Model
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2009
Completion date
February 28, 2010
Enrollment
291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methotrexate adverse reaction